Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBioPharma Dive ↗
Novo's latest alliance involves injectables given every one to three months. Elsewhere, Nektar won a legal spa…
The WeekKFF Health News ↗
This fact sheet summarizes federal, state, and local policies on paid family and medical leave and paid sick l…
The WeekPharmaVoice ↗
Some of the biggest news and trends captured in PharmaVoice's newsletter this week. Sign up here to receive t…
The WeekBriefing
STAT reported a gap between White House claims of universal state interest in a Medicaid drug pricing initiati…
The WeekDrug Channels ↗
Today's guest post comes from Divya Iyer, SVP, Head of Revenue, Pharma Direct at GoodRx. Divya examines how AI…
The WeekPharmaceutical Technology ↗
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for condit…
The WeekSTAT News ↗
Virtually all of the 175,000 public comments on a 2022 FDA proposal to ban menthol cigarettes were form letter…
The WeekBioPharma Dive ↗
ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO …
The WeekFDA (Drugs) ↗
The Food and Drug Administration is announcing a public meeting to discuss proposed recommendations for the re…
The WeekKFF Health News ↗
Section 1115 Medicaid waivers can allow states to test new approaches in Medicaid that differ from what is req…
The WeekPharmaVoice ↗
Pressed by lawmakers on Thursday, Trump's pick as the next FDA chief said she'd "follow the law" on vaccine-re…
The WeekPharmaVoice ↗
As more psychedelic drugs move toward market, developers are testing how far patent protection can extend arou…
The WeekFiercePharma ↗
The Ozempic and Wegovy maker's CEO said he's open to a direct listing of Novo's shares on the New York Stock E…
The WeekFierceBiotech ↗
Kyverna 'resetting conversation' with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
As two Big Pharma players in the autoimmune CAR-T space face unexpected safety setbacks, Kyverna Therapeutics …
The WeekBriefing
The White House said all 50 states applied to participate in a new Medicaid model aimed at bringing most-favor…
The WeekSTAT News ↗
Gilead Sciences' top executives have been emphatically bullish about the biotech's years-long push to develop …
The WeekPharmaceutical Technology ↗
Genialis and Inventia Life Science have partnered to enhance pancreatic cancer treatment testing and match the…
The WeekBioPharma Dive ↗
Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human …
The WeekPharmaVoice ↗
At a "capital markets day" in London, executives outlined a roadmap to better compete with key rival Eli Lilly…
The WeekPharmaVoice ↗
Lilly no longer publicly lists its earliest clinical programs. The move could buy the pharma giant time to tes…
The WeekFiercePharma ↗
AstraZeneca has re-upped its UNICEF-partnered Young Health Programme, committing to a new five-year phase that…
The WeekFierceBiotech ↗
GSK has been operating a strategy of "balancing the West and the East" since the Big Pharma's eyes were opened…
The WeekBriefing
Telix’s $1.65 billion up-front deal for ITM is about more than pipeline bulk. The manufacturing angle may be t…
The WeekSTAT News ↗
Some health insurers push back on a Medicare proposal that would disrupt how doctors can bill for remotely mon…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.